Chongqing University Cancer Hospital - Chongqing Cancer Hospital

Chongqing 400030

0 studies enrolling now · 1 studies all time

What they study most

Refractory Diffuse Large B-Cell Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma

Studies at this site

• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling